Duchenne muscular dystrophy: pathogenesis and pharmacology
- 1 March 1987
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 8 (3) , 109-113
- https://doi.org/10.1016/0165-6147(87)90085-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy geneNature, 1986
- The pathogenesis of Duchenne muscular dystrophy: Significance of experimental observationsMedical Hypotheses, 1985
- Clinical trials of allopurinol in Duchenne muscular dystrophyMedical Hypotheses, 1985
- Calcium and magnesium content in fetuses at risk and prenecrotic Duchenne muscular dystrophyNeurology, 1984
- Letters to the editorMuscle & Nerve, 1984
- Drug Trial of Superoxide Dismutase in Duchenne's Muscular DystrophyArchives of Neurology, 1982
- Clinical trial in duchenne dystrophy. I. The design of the protocolMuscle & Nerve, 1981
- The use and misuse of androgensMetabolism, 1980
- MANAGEMENT OF MUSCULAR DYSTROPHY: Pharmacological and Physical AspectsBritish Medical Bulletin, 1980
- THE METABOLIC HOMŒOSTATIC ROLE OF MUSCLE AND ITS FUNCTION AS A STORE OF PROTEINThe Lancet, 1977